Identification of an emphysema-associated genetic variant near TGFB2 with regulatory effects in lung fibroblasts

  1. Margaret M Parker
  2. Yuan Hao
  3. Feng Guo
  4. Betty Pham
  5. Robert Chase
  6. John Platig
  7. Michael H Cho
  8. Craig P Hersh
  9. Victor J Thannickal
  10. James Crapo
  11. George Washko
  12. Scott H Randell
  13. Edwin K Silverman
  14. Raúl San José Estépar
  15. Xiaobo Zhou  Is a corresponding author
  16. Peter J Castaldi  Is a corresponding author
  1. Brigham and Women's Hospital, United States
  2. University of Alabama at Birmingham, United States
  3. National Jewish Health, United States
  4. University of North Carolina at Chapel Hill, United States

Abstract

Murine studies have linked TGF-b signaling to emphysema, and human genome-wide association studies (GWAS) studies of lung function and COPD have identified associated regions near genes in the TGF-b superfamily. However, the functional regulatory mechanisms at these loci have not been identified. We performed the largest GWAS of emphysema patterns to date, identifying ten GWAS loci including an association peak spanning a 200kb region downstream from TGFB2. Integrative analysis of publicly available eQTL, DNaseI, and chromatin conformation data identified a putative functional variant, rs1690789, that may regulate TGFB2 expression in human fibroblasts. Using chromatin conformation capture, we confirmed that the region containing rs1690789 contacts the TGFB2 promoter in fibroblasts, and CRISPR/Cas-9 targeted deletion of a ~100bp region containing rs1690789 resulted in decreased TGFB2 expression in primary human lung fibroblasts. These data provide novel mechanistic evidence linking genetic variation affecting the TGF-b pathway to emphysema in humans.

Data availability

COPDGene genetic data and RNA-seq data have been deposited in dbGaP under accession code phs000765.v3.p2. To access these data users may apply for access to the dbGaP data repository (https://www.ncbi.nlm.nih.gov/books/NBK482114/).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Margaret M Parker

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  2. Yuan Hao

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  3. Feng Guo

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  4. Betty Pham

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  5. Robert Chase

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  6. John Platig

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  7. Michael H Cho

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Michael H Cho, reports grants from GSK and personal fees from Genentech.
  8. Craig P Hersh

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Craig P Hersh, reports personal fees from Mylan, personal fees from AstraZeneca, Concert Pharmaceuticals, 23andMe, grants from Novartis, and Boehringer-Ingelheim.
  9. Victor J Thannickal

    Department of Medicine, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
  10. James Crapo

    National Jewish Health, Denver, United States
    Competing interests
    No competing interests declared.
  11. George Washko

    Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    George Washko, reports grants and other support from Boehringer Ingelheim, PulmonX, BTG Interventional Medicine, Janssen Pharmaceuticals, and GSK.
  12. Scott H Randell

    Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    Scott H Randell, reports receiving personal fees from Amgen.
  13. Edwin K Silverman

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Edwin K Silverman, received honoraria from Novartis for Continuing Medical Education Seminars and grant and travel support from GlaxoSmithKline.
  14. Raúl San José Estépar

    Applied Chest Imaging Laboratory, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Raúl San José Estépar, reports personal fees from Boehringer Ingelheim, Eolo Medical, and Toshiba.
  15. Xiaobo Zhou

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    For correspondence
    xiaobo.zhou@channing.harvard.edu
    Competing interests
    No competing interests declared.
  16. Peter J Castaldi

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    For correspondence
    peter.castaldi@channing.harvard.edu
    Competing interests
    Peter J Castaldi, has received research support and consulting fees from GSK and Novartis.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9920-4713

Funding

National Heart, Lung, and Blood Institute (R01 HL124233)

  • Peter J Castaldi

National Heart, Lung, and Blood Institute (R01 HL126596)

  • Peter J Castaldi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, Parker et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,776
    views
  • 201
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Margaret M Parker
  2. Yuan Hao
  3. Feng Guo
  4. Betty Pham
  5. Robert Chase
  6. John Platig
  7. Michael H Cho
  8. Craig P Hersh
  9. Victor J Thannickal
  10. James Crapo
  11. George Washko
  12. Scott H Randell
  13. Edwin K Silverman
  14. Raúl San José Estépar
  15. Xiaobo Zhou
  16. Peter J Castaldi
(2019)
Identification of an emphysema-associated genetic variant near TGFB2 with regulatory effects in lung fibroblasts
eLife 8:e42720.
https://doi.org/10.7554/eLife.42720

Share this article

https://doi.org/10.7554/eLife.42720

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Eric V Strobl, Eric Gamazon
    Research Article

    Root causal gene expression levels – or root causal genes for short – correspond to the initial changes to gene expression that generate patient symptoms as a downstream effect. Identifying root causal genes is critical towards developing treatments that modify disease near its onset, but no existing algorithms attempt to identify root causal genes from data. RNA-sequencing (RNA-seq) data introduces challenges such as measurement error, high dimensionality and non-linearity that compromise accurate estimation of root causal effects even with state-of-the-art approaches. We therefore instead leverage Perturb-seq, or high-throughput perturbations with single-cell RNA-seq readout, to learn the causal order between the genes. We then transfer the causal order to bulk RNA-seq and identify root causal genes specific to a given patient for the first time using a novel statistic. Experiments demonstrate large improvements in performance. Applications to macular degeneration and multiple sclerosis also reveal root causal genes that lie on known pathogenic pathways, delineate patient subgroups and implicate a newly defined omnigenic root causal model.

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Steven Henikoff, David L Levens
    Insight

    A new method for mapping torsion provides insights into the ways that the genome responds to the torsion generated by RNA polymerase II.